BIOGEN ALZHEIMER APPROVED, page-5

TripAces: "...with, lets say 'weak' data,...."

TripAces/others: JIMHO, the data are extremely weak! Let me quote from an article I did read on-line from the Guardian newspaper:
QUOTES:
"Amazingly, the FDA have sidestepped available clinical trial outcomes that indicated the drug probably doesn't work.
The FDA rejected the application in November, when its members were split on the merits. Three of its advisers went public, writing in a scientific journal that there was not enough evidence that it worked. They were concerned that if the drug were approved largely because of the dearth of drugs for Alzheimer's, it would lover the bar for the future."
END OF QUOTES

What it will mean for NEU: Hopefully, NEU's partner in the USA will have the same kind of 'strong connections' within the FDA to push through - regardless of how excellent (hopefully) or even when less so - the results in fact are/will be.......

wasa